focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second International Distribution Contract Signed

10 Sep 2020 07:30

RNS Number : 5960Y
Zoetic International PLC
10 September 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

 

Zoetic International plc

("Zoetic" or the "Company")

 

Second International Distribution Contract Signed

 

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, is pleased to announce that it has signed its second international distribution contract, as well as continued progress with its core CBD business.

 

Highlights

 

● Executed a second international distribution agreement covering the distribution of the Company's Chill brand of tobacco alternative CBD products in over 15 markets across Europe

 

● Additional stocks of Chill brand smokeable products secured following significant demand

 

Agreement reached with major European distributor

 

Further to the announcement on 2 September 2020 that Zoetic was in final negotiations of an international distribution contract, the Company is pleased to announce that an agreement has been reached with a major new international distributor for its Chill brand of tobacco alternative CBD products (the "Agreement"). The Agreement will see the Company's premium CBD offering reach consumers in over 15 markets across the European Union, with thousands of stores making preparations to stock the Chill range. In a promising development, this physical footprint will be complemented by an established eCommerce presence which saw substantial revenue generated from vaping products alone during the last financial period.

 

The Agreement follows directly from the announcement that the Company had signed its first international distribution contract for the Chill range of products on 6 July 2020, illustrating that there is extensive interest and demand for the Company's products on a multinational level. The Company continues to identify and pursue new opportunities globally and is keen to sustain the rapid rate of growth that it has enjoyed so far.

 

Trevor Taylor, Co-CEO of Zoetic, commented, "We are delighted to have secured a further international distribution partner for the Chill brand. This agreement serves to affirm the quality and popularity that our products enjoy. Our new partner's 15 years of trading experience within the EU tobacco market will provide an excellent platform to enable the sale of our products to consumers across Europe."

 

Replenishment of stocks of Chill brand smokeable product range

 

Following significant demand for its Chill brand products, Zoetic is pleased to have restocked its range of tobacco alternative CBD smokes online. With hemp, calm and mint varieties now back in stock, the Company will focus on continuing to grow its market share of its top-quality, USDA certified organic products.

 

Via its Chill brand, the Company believes it has the market's only THC-free, nicotine-free, CBD smokes. The Company is very pleased with the demand for its products, which is matched by the continual growth in popularity of the CBD chewable pouch market and ever-expanding interest in the Company's range of mint smokes which are continuing to benefit from the regulation of tobacco-based menthol cigarettes, which are now banned in Brazil, Canada, Ethiopia, Turkey, Moldova, the European Union and the United Kingdom.

 

The Company expects to launch with the US distributors over the next few months whilst the groundwork and logistics for the international distributors is finalised. The Company hopes to have sales in non-US markets for the Chill brand before the end of 2020.

 

Antonio Russo, Co-CEO of Zoetic, commented, "The depletion of our Chill brand stocks stands testament to the high regard in which our products are held. We are extremely happy to be returning Chill brand smokes to the pockets of consumers across our core US market and will continue to lead the way in the development and distribution of quality CBD products."

 

Trevor Taylor, Co-CEO of Zoetic, commented, "We knew our smokable line was going to be a big hit and are pleased to get our inventories built up ahead of the rollout of our larger retail launch, both in the US and internationally."

 

ENDS

 

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss / Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAKNEFFLEEEA
Date   Source Headline
15th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 201610:15 amRNSDisposal of Warrants and Interest in Shares
15th Jun 20167:53 amRNSFinal Results
15th Jun 20167:50 amRNSHelios Two Transaction
14th Jun 201612:30 pmRNSIssue of Shares
10th Jun 20167:00 amRNSDT Ultravert Update
8th Jun 20167:00 amRNSAcquisition of Helium Licences in Montana
6th Jun 201611:34 amRNSInterest in Shares
31st May 20167:00 amRNSIssue of Shares
23rd May 20167:00 amRNSLicence Agreement with Calfrac for DT UltraVert
20th May 20167:00 amRNSIncreases Uranium Acreage in Utah
20th May 20167:00 amRNSIssue of Shares
18th May 20169:00 amRNSFurther Acquisition of Licences in North Dakota
13th May 20167:00 amRNSIssue of Shares
9th May 20167:00 amRNSIssue of Shares
5th May 20164:40 pmRNSSecond Price Monitoring Extn
5th May 20164:35 pmRNSPrice Monitoring Extension
5th May 20167:00 amRNSIssue of Shares
28th Apr 20161:00 pmRNSIssue of Shares
27th Apr 201612:45 pmRNSResults of General Meeting
27th Apr 20167:00 amRNSShare Subscription Raises £519,093
25th Apr 20167:49 amRNSCorporate Update
1st Apr 20168:00 amRNSPublication of Circular and Notice of GM
30th Mar 20167:00 amRNSDoubles Utah Uranium Acreage
18th Mar 20162:45 pmRNSSigns Agreement for Potential Uranium Discovery
15th Mar 20167:00 amRNSIssue of Shares
11th Mar 20167:00 amRNSIssue of Shares
22nd Feb 20167:00 amRNSIssue of Shares
17th Feb 20167:00 amRNSIssue of Shares
11th Feb 201610:00 amRNSIssue of Shares
3rd Feb 20168:30 amRNSReadmission to Trading on London Stock Exchange
29th Jan 20167:00 amRNSPublication of Prospectus; Readmission; Placing
27th Nov 20157:00 amRNSInterim Results
16th Nov 20157:00 amRNSAcquires Leasehold Interest
25th Sep 20157:00 amRNSLicence Agreement with Schlumberger
19th Aug 20157:00 amRNSAppointment of Financial Adviser and Broker
30th Jun 20154:04 pmRNSHolding(s) in Company
25th Jun 20157:42 amRNSSuspension
25th Jun 20157:25 amRNSSuspension of Trading
29th May 20157:00 amRNSIssue of Equity
26th May 20157:01 amRNSCompletes Oilfield Technology Acquisition
12th May 20157:00 amRNSStrategy Update & Oilfield Technology Acquisition
25th Mar 20158:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.